Oncology Coding Break – Female Reproductive System Part 3: Cervix Uteri

Oncology, Oncology Coding Break, Registry Education

<a href="https://www.registrypartners.com/author/heather-donohue/" target="_self">Heather Donohue</a>

Heather Donohue

Educator & Internship Program Manager

Published/Updated Date: September 30, 2024

https://youtu.be/dhwrlS4Ag10

The September Oncology Coding Break is Part 3 of a 4 Part Series on the Female Reproductive System. This month, we will focus on the Cervix Uteri.

To get things started, Melissa Meador, ph.D., ODS-C will discuss cervix anatomy, with a particular focus on the type of cells that make up the cervix and the endocervix, as well as explain the transitional zone. Then, Melissa will discuss Human Papilloma Virus and the organs most effected by this virus. Melissa will explain exactly how the HPV virus infects its host, the most common strains of the HPV virus, and the testing methods used to detect this virus. We have specific histology codes that should be used when the cervical cancer is associated with or independent of HPV, which Melissa explains. 

Then, Heather Donohue, ODS-C, will discuss surgical treatments, pointing out which treatments qualify for path staging, and which do not. Heather will briefly discuss the most common systemic therapies, as well as the radiation therapies for cervical cancers. Heather gives an in-depth explanation of coding radiation therapy when more than 3 phases are given, and how this type of scenario should be captured in the coding fields, as well as the text. 

Be sure to join us for Part 4 of the series, which is a Special 1-Hour Live Oncology Coding Break on All Gyn Sites–Cancers of the Female Reproductive System!

Click here to download this month’s presentation as a PDF.

Related

Why Oncology Programs Can’t Afford Data Gaps

Why Oncology Programs Can’t Afford Data Gaps

Every important decision an oncology program makes depends on data. Cancer committees review quality measures to evaluate program performance. Physicians use registry reports to monitor treatment patterns and outcomes. Hospital leaders rely on registry data to guide...

Breaking the Cycle of “Keeping Up” in Registry Management

Breaking the Cycle of “Keeping Up” in Registry Management

For many healthcare organizations, registry operations become centered on keeping pace with today's work instead of improving how the work gets done. Production continues, and reporting requirements are met, but there is rarely enough time to evaluate workflows....

The Hidden Cost of Inefficient Cancer Registry Workflows

The Hidden Cost of Inefficient Cancer Registry Workflows

Healthcare organizations depend on cancer registry data to evaluate outcomes, monitor quality, support research, meet accreditation requirements, and guide strategic decision-making. The value of that data depends on its accuracy, completeness, and timeliness, making...

Stay in Touch

Get our latest articles, registry insights, and company news straight to your inbox.

This field is for validation purposes and should be left unchanged.